
Marcela M. Cordero Garcia
Examiner (ID: 4537)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658 |
| Total Applications | 1421 |
| Issued Applications | 950 |
| Pending Applications | 83 |
| Abandoned Applications | 394 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12965050
[patent_doc_number] => 09874570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Method of detecting at least one mechanism of resistance to cephalosporins by mass spectrometry
[patent_app_type] => utility
[patent_app_number] => 15/295061
[patent_app_country] => US
[patent_app_date] => 2016-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 115499
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295061
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/295061 | Method of detecting at least one mechanism of resistance to cephalosporins by mass spectrometry | Oct 16, 2016 | Issued |
Array
(
[id] => 11443194
[patent_doc_number] => 20170044214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'SELECTIVE DELIVERY MOLECULES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/295482
[patent_app_country] => US
[patent_app_date] => 2016-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 55698
[patent_no_of_claims] => 238
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295482
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/295482 | Selective delivery molecules and methods of use | Oct 16, 2016 | Issued |
Array
(
[id] => 11894084
[patent_doc_number] => 09764004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Glucagon receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 15/293324
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18011
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15293324
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/293324 | Glucagon receptor agonists | Oct 13, 2016 | Issued |
Array
(
[id] => 13577319
[patent_doc_number] => 20180340208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => COMPOSITIONS AND METHODS FOR ABSOLUTE QUANTIFICATION OF PROTEINS
[patent_app_type] => utility
[patent_app_number] => 15/768421
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768421
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/768421 | COMPOSITIONS AND METHODS FOR ABSOLUTE QUANTIFICATION OF PROTEINS | Oct 13, 2016 | Abandoned |
Array
(
[id] => 15385655
[patent_doc_number] => 10534005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-14
[patent_title] => Method for the in vitro diagnosis of thyroid diseases
[patent_app_type] => utility
[patent_app_number] => 15/768626
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2434
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768626
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/768626 | Method for the in vitro diagnosis of thyroid diseases | Oct 13, 2016 | Issued |
Array
(
[id] => 13024531
[patent_doc_number] => 10034877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-31
[patent_title] => Treatment for diabetes in patients inappropriate for metformin therapy
[patent_app_type] => utility
[patent_app_number] => 15/287228
[patent_app_country] => US
[patent_app_date] => 2016-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11025
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287228
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/287228 | Treatment for diabetes in patients inappropriate for metformin therapy | Oct 5, 2016 | Issued |
Array
(
[id] => 13011689
[patent_doc_number] => 10028945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
[patent_app_type] => utility
[patent_app_number] => 15/285818
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 20
[patent_no_of_words] => 48658
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 561
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15285818
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/285818 | Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof | Oct 4, 2016 | Issued |
Array
(
[id] => 13490309
[patent_doc_number] => 20180296697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => ENZYME-RESPONSIVE PEPTIDE NANOFIBER COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/764188
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764188
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/764188 | Enzyme-responsive peptide nanofiber compositions and uses thereof | Sep 29, 2016 | Issued |
Array
(
[id] => 13493033
[patent_doc_number] => 20180298059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => A NEW TYPE POLYPEPTIDE TARGETING TUMOURS
[patent_app_type] => utility
[patent_app_number] => 15/767146
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767146
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767146 | Type polypeptide targeting tumours | Sep 29, 2016 | Issued |
Array
(
[id] => 16680726
[patent_doc_number] => 10940182
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Use of modified vasoactive intestinal peptides in the treatment of hypertension
[patent_app_type] => utility
[patent_app_number] => 15/276151
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11222
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15276151
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/276151 | Use of modified vasoactive intestinal peptides in the treatment of hypertension | Sep 25, 2016 | Issued |
Array
(
[id] => 15606221
[patent_doc_number] => 10584160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Glypican-3-binding fibronectin based scaffold molecules
[patent_app_type] => utility
[patent_app_number] => 15/760449
[patent_app_country] => US
[patent_app_date] => 2016-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 54
[patent_no_of_words] => 43755
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760449
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760449 | Glypican-3-binding fibronectin based scaffold molecules | Sep 21, 2016 | Issued |
Array
(
[id] => 11382875
[patent_doc_number] => 20170008931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'Melanocortin-1 Receptor-Specific Cyclic Hexapeptides'
[patent_app_type] => utility
[patent_app_number] => 15/268761
[patent_app_country] => US
[patent_app_date] => 2016-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28658
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15268761
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/268761 | Melanocortin-1 receptor-specific cyclic hexapeptides | Sep 18, 2016 | Issued |
Array
(
[id] => 13077079
[patent_doc_number] => 10058594
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Treatment of depression and PTSD
[patent_app_type] => utility
[patent_app_number] => 15/268979
[patent_app_country] => US
[patent_app_date] => 2016-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5245
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15268979
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/268979 | Treatment of depression and PTSD | Sep 18, 2016 | Issued |
Array
(
[id] => 16492370
[patent_doc_number] => 10858395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Skin-penetrating peptide and method for using same
[patent_app_type] => utility
[patent_app_number] => 15/759134
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 55
[patent_no_of_words] => 15504
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759134
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/759134 | Skin-penetrating peptide and method for using same | Sep 8, 2016 | Issued |
Array
(
[id] => 14519087
[patent_doc_number] => 10336790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Anti-microbial peptides and method for designing novel anti-microbial peptides
[patent_app_type] => utility
[patent_app_number] => 15/259942
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11869
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15259942
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/259942 | Anti-microbial peptides and method for designing novel anti-microbial peptides | Sep 7, 2016 | Issued |
Array
(
[id] => 14775143
[patent_doc_number] => 20190262469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => PROTOCELLS TO TREAT MICROBIAL INFECTION AND FOR SYNERGISTIC DELIVERY
[patent_app_type] => utility
[patent_app_number] => 15/757254
[patent_app_country] => US
[patent_app_date] => 2016-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757254
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/757254 | PROTOCELLS TO TREAT MICROBIAL INFECTION AND FOR SYNERGISTIC DELIVERY | Sep 1, 2016 | Abandoned |
Array
(
[id] => 13067641
[patent_doc_number] => 10054597
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-21
[patent_title] => Method for identifying and quantifying carboxyethyl valine modified haemoglobin
[patent_app_type] => utility
[patent_app_number] => 15/254539
[patent_app_country] => US
[patent_app_date] => 2016-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 4952
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15254539
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/254539 | Method for identifying and quantifying carboxyethyl valine modified haemoglobin | Aug 31, 2016 | Issued |
Array
(
[id] => 11602607
[patent_doc_number] => 20170119908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'Fluorescent Imaging Agents'
[patent_app_type] => utility
[patent_app_number] => 15/250038
[patent_app_country] => US
[patent_app_date] => 2016-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 31941
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15250038
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/250038 | Fluorescent imaging agents | Aug 28, 2016 | Issued |
Array
(
[id] => 13415945
[patent_doc_number] => 20180259515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => METHODS FOR MOLECULAR CLASSIFICATION OF FATTY LIVER BY HIGH-THROUGHPUT PROTEIN POST-TRANSLATIONAL MODIFICATIONS
[patent_app_type] => utility
[patent_app_number] => 15/755399
[patent_app_country] => US
[patent_app_date] => 2016-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755399
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/755399 | Methods for molecular classification of fatty liver by high-throughput protein post-translational modifications | Aug 24, 2016 | Issued |
Array
(
[id] => 13028279
[patent_doc_number] => 10036756
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-31
[patent_title] => Mass spectrometry analysis of mutant polypeptides in biological samples
[patent_app_type] => utility
[patent_app_number] => 15/245393
[patent_app_country] => US
[patent_app_date] => 2016-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9781
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15245393
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/245393 | Mass spectrometry analysis of mutant polypeptides in biological samples | Aug 23, 2016 | Issued |